[1]Mihaljevic AL, Michalski CW, Friess H, et al. Molecular mechanism of pancreatic cancer——understanding proliferation, invasion, and metastasis[J]. Langenbecks Arch Surg, 2010,395(4):295-308.
[2]Haage A, Schneider IC. Cellular contractility and extracellular matrix stiffness regulate matrix met alloproteinase activity in pancreatic cancer cells[J]. FASEB J, 2014, 28(8): 3589-3599.[3]Pahwa S, Stawikowski MJ, Fields GB. Monitoring and Inhibiting MT1-MMP during Cancer Initiation and Progression[J]. Cancers, 2014,6(1):416-435.
[4]Haage A, Nam DH, Ge X, et al. Matrix met alloproteinase-14 is a mechanically regulated activator of secreted MMPs and invasion[J]. Biochem Biophys Res Commun, 2014, 450(1):213-218.
[5]Hill R, Li Y, Tran LM, et al. Cell intrinsic role of COX-2 in pancreatic cancer development[J]. Mol Cancer Ther, 2012,11(10):2127-2137.
[6]Vosooghi M, Amini M. The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies[J]. Expert Opin Drug Discov, 2014,9(3):255-267.
[7]Chen WQ, Liang D, Zhang SW, et al. Pancreatic cancer incidence and mortality patterns in china, 2009[J]. Asian Pac J Cancer Prev, 2013,14(12):7321-7324.
[8]Long J, Luo GP, Xiao ZW, et al. Cancer statistics: current diagnosis and treatment of pancreatic cancer in Shanghai, China[J]. Cancer Lett, 2014,346(2):273-277.
[9]Sadeghi-Aliabadi H, Aliasgharluo M, Fattahi A, et al. In vitro cytotoxic evaluation of some synthesized COX-2 inhibitor derivatives against a panel of human cancer cell lines[J]. Res Pharm Sci, 2013,8(4):298-303.
[10]Wang ZL, Fan ZQ, Jiang HD, et al. Selective Cox-2 inhibitor celecoxib induces epithelial-mesenchymal transition in human lung cancer cells via activating MEK-ERK signaling[J]. Carcinogenesis, 2013,34(3):638-646.
[11]Ding N, Cui XX, Gao Z, et al. A triple combination of atorvastatin, Celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors[J]. Int J Oncol, 2014,44(6):2139-2145.
[12]Poincloux R, Lizarraga F, Chavrier P. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia[J]. J Cell Sci, 2009,122(Pt 17):3015-3024.
[13]Hu M, Peluffo G, Chen H, et al. Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast[J]. Proc Natl Acad Sci USA, 2009,106(9):3372-3377.
[14]Annabi B, Laflamme C, Sina A, et al. A MT1-MMP/NF-kappaB signaling axis as a checkpoint controller of COX-2 expression in CD133+ U87 glioblastoma cells[J]. J Neuroinflammation, 2009,6(8): 1186-1196. |